----
Current ValuationThe current P/E ratio is -18.13, within the reasonable range, cheaper than 68.4% of the time in the past 5 years, and the industry ranks 59/78, the industry Median -5.01.
-18.13xP/E
HK$5.48Stock price
HK$-0.30Earnings per share
-18.13xP/E
Stock priceHK$5.48Earnings per shareHK$-0.30
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -5.05x
- Typical range
- -21.99x–-3.07x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0158316474632
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
09926HKAKESO | -74.88x | 75.50% | HK$83.39B |
09688HKZAI LAB | -16.45x | 17.69% | HK$25.60B |
01877HKJUNSHI BIO | -35.02x | 83.59% | HK$16.09B |
07666HKMETIS TECHBIO-P | -32.37x | 96.67% | HK$13.18B |
02627HKAB&B BIO-TECH-B | -46.87x | -- | HK$11.54B |
06855HKASCENTAGE | -6.46x | 19.08% | HK$10.93B |
09606HKDUALITYBIO-B | -5.96x | 85.35% | HK$9.87B |
01952HKEVEREST MED | -153.55x | 326.79% | HK$9.53B |
02595HKGENFLEET-B | -5.95x | 66.07% | HK$9.02B |
02616HKCSTONE PHARMA-B | -18.13x | 1.09% | HK$8.75B |
02493HKMABWELL-B | -6.63x | -- | HK$8.11B |
09887HKLEADS BIOLABS-B | -25.08x | 3.57% | HK$7.71B |
06938HKRIBOLIFE-B | -39.45x | 29.56% | HK$7.71B |
02335HKMICOT PHARMA-B | -16.86x | 37.52% | HK$7.07B |
02171HKCARSGEN-B | -64.59x | 52.33% | HK$6.63B |
09966HKALPHAMAB-B | -29.30x | -- | HK$5.94B |
00775HKCKLIFE SCIENCES | -80.22x | -- | HK$5.19B |
01672HKASCLETIS-B | -7.38x | 78.53% | HK$5.02B |
02256HKABBISKO-B | -8.87x | 797.83% | HK$4.77B |
01779HKLONGBIO-B | -19.01x | -- | HK$4.73B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
